HLS THERAPEUTICS INC. earnings per share and revenue

74D earnings per share for the last quarter are -0.15 EUR whereas the estimation was -0.09 EUR which accounts for -78.95% surprise. Företagets omsättning för samma period uppgår till 14.37 M EUR trots den uppskattade siffran 14.50 M EUR. Estimated earnings per share for the next quarter are -0.15 EUR, and revenue is expected to reach 13.49 M EUR. Also watch annual changes over time to get a bigger picture of 74D earnings per share and revenue dynamics.